Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Megan Othus

Showing results (1-10 of 231) with videos related to

Pageof 24
Sort By:
Statistics in Biosciences|December 14, 2011
A Gaussian Copula Model for Multivariate Survival DataMegan Othus, Yi Li
Statistics in Medicine|November 26, 2022
RECeUS: Ratio estimation of censored uncured subjects, a different approach for assessing cure model appropriateness in studies with long-term survivorsSubodh Selukar, Megan Othus
Journal of Applied Statistics|May 1, 2012
Change point-cure models with application to estimating the change-point effect of age of diagnosis among prostate cancer patientsMegan Othus, Yi Li, Ram Tiwari
JAMA Oncology|June 4, 2026
Fluids for Immune Checkpoint Inhibitor Diabetic Ketoacidosis-ReplyZoe Quandt, Megan Othus, Elad Sharon
Blood Reviews|August 2, 2025
Synthetic control arms and other uses of external data in clinical trials for hematological malignanciesSubodh Selukar, Vivien Yin, Megan Othus
JCO Clinical Cancer Informatics|April 8, 2021
Accounting for All Patients in Waterfall PlotsJames Moon, Michael LeBlanc, Megan Othus
Cancer|April 8, 2011
Melanoma's deadly march to the brain: by what route, and can it be stopped?Megan Othus, James Moon, Kim Margolin
Cancer|July 13, 2023
Signal detection in real-world data and confirmation in clinical trials: Diabetes as a case study for a conversation worth havingElad Sharon, Megan Othus, Zoe Eloise Quandt
Clinical Trials (London, England)|May 4, 2016
Information time scales for interim analyses of randomized clinical trialsBoris Freidlin, Megan Othus, Edward L Korn
Cells|February 25, 2025
Significance of Measurable Residual Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid LeukemiaMargery Gang, Megan Othus, Roland B Walter
Pageof 24

Showing results (1-10 of 231) with videos related to

Sort By:
Pageof 24
Statistics in Biosciences|December 14, 2011
A Gaussian Copula Model for Multivariate Survival DataMegan Othus, Yi Li
Statistics in Medicine|November 26, 2022
RECeUS: Ratio estimation of censored uncured subjects, a different approach for assessing cure model appropriateness in studies with long-term survivorsSubodh Selukar, Megan Othus
Journal of Applied Statistics|May 1, 2012
Change point-cure models with application to estimating the change-point effect of age of diagnosis among prostate cancer patientsMegan Othus, Yi Li, Ram Tiwari
JAMA Oncology|June 4, 2026
Fluids for Immune Checkpoint Inhibitor Diabetic Ketoacidosis-ReplyZoe Quandt, Megan Othus, Elad Sharon
Blood Reviews|August 2, 2025
Synthetic control arms and other uses of external data in clinical trials for hematological malignanciesSubodh Selukar, Vivien Yin, Megan Othus
JCO Clinical Cancer Informatics|April 8, 2021
Accounting for All Patients in Waterfall PlotsJames Moon, Michael LeBlanc, Megan Othus
Cancer|April 8, 2011
Melanoma's deadly march to the brain: by what route, and can it be stopped?Megan Othus, James Moon, Kim Margolin
Cancer|July 13, 2023
Signal detection in real-world data and confirmation in clinical trials: Diabetes as a case study for a conversation worth havingElad Sharon, Megan Othus, Zoe Eloise Quandt
Clinical Trials (London, England)|May 4, 2016
Information time scales for interim analyses of randomized clinical trialsBoris Freidlin, Megan Othus, Edward L Korn
Cells|February 25, 2025
Significance of Measurable Residual Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid LeukemiaMargery Gang, Megan Othus, Roland B Walter
Pageof 24